8-K: ATI Physical Therapy to be Delisted from NYSE, Shares to Trade on OTC Pink Market

ATI Physical Therapy's Class A common stock will be delisted from the New York Stock Exchange due to non-compliance with listing rules and will transition to the OTC Pink Market.

Summary

• ATI Physical Therapy has received notification from the New York Stock Exchange (NYSE) that its Class A common stock will be delisted.
• The delisting is a result of the company's failure to maintain an average global market capitalization of at least $15 million over a 30-day period.
• Trading of ATI's common stock on the NYSE was suspended after market close on December 3, 2024.
• The company does not intend to appeal the NYSE's decision.
• ATI's stock is expected to begin trading on the OTC Pink Market.
• The OTC Pink Market is a less liquid market, which could negatively impact the trading price and liquidity of the stock.
• The company is in discussions to obtain interim financing to provide liquidity to stockholders.
• The transition to the OTC Pink Market is not expected to affect the company's business operations, relationships, or SEC reporting obligations.

Sentiment

Score: 2

Explanation: The document indicates significant financial distress, delisting from a major exchange, and a move to a less liquid market, all of which are highly negative signals for investors. The company's ability to continue as a going concern is also in doubt.

Positives

• The company is actively seeking interim financing to provide liquidity to its stockholders.
• The transition to the OTC Pink Market is not expected to affect the company's business operations, relationships with partners or employees, or its SEC reporting obligations.
• Management states they have made meaningful progress strengthening operating performance and positioning the company for growth.

Negatives

• The company failed to maintain the minimum market capitalization of $15 million over 30 consecutive trading days, leading to delisting from the NYSE.
• The stock will now trade on the OTC Pink Market, which is a less liquid market and could further depress the trading price.
• There is no assurance that the stock will continue to trade on the OTC Pink Market or that broker-dealers will provide public quotes.
• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• There are risks associated with liquidity and capital markets, including the company's ability to generate sufficient cash flows.
• The company may not be able to meet financial covenants as required by its 2022 Credit Agreement.
• Risks related to outstanding indebtedness, rising interest rates, and the potential need for additional financing exist.
• The company is dependent on governmental and third-party payors for reimbursement, and changes in reimbursement rates could adversely affect financial results.
• The company faces competition in a rapidly changing industry and may struggle to retain skilled physical therapists.
• The company's operations are subject to extensive regulation and macroeconomic uncertainty.
• There are risks associated with the company's reliance on IT infrastructure and potential security breaches.
• The company may face further impairments of goodwill and other intangible assets.
• The company's ability to maintain effective internal control over financial reporting is a risk.
• The delisting from the NYSE could negatively impact the company's stock price and investor confidence.

Future Outlook

The company is seeking interim financing to provide near-term liquidity for stockholders and is transitioning to the OTC Pink Market. The company's future is uncertain due to liquidity concerns and the delisting.

Management Comments

• Sharon Vitti, Chief Executive Officer of ATI, stated that they have made meaningful progress strengthening operating performance and positioning the company for growth.
• Joe Jordan, Chief Financial Officer of ATI, said that the interim financing discussions are aligned to delivering liquidity to stockholders and providing a possible path to a simpler capital structure.

Industry Context

The delisting of ATI Physical Therapy from the NYSE highlights the challenges faced by companies in the healthcare sector, particularly those with high debt and reliance on reimbursements. The move to the OTC Pink Market is a significant downgrade and reflects the company's financial struggles.

Comparison to Industry Standards

• The delisting of ATI due to failing to maintain a $15 million market cap is a significant negative event, as most publicly traded healthcare companies on major exchanges maintain significantly higher valuations.
• Companies like Select Medical Holdings (SEM) and U.S. Physical Therapy (USPH) are examples of publicly traded physical therapy providers that maintain listings on major exchanges and have significantly higher market capitalizations, indicating a stark contrast in financial health and investor confidence.
• The move to the OTC Pink Market is typically associated with companies facing financial distress or regulatory issues, which is not a common occurrence for established players in the healthcare sector.

Stakeholder Impact

• Shareholders will experience a significant negative impact due to the delisting and the move to a less liquid market, potentially leading to a decrease in stock value.
• Employees may experience uncertainty due to the company's financial challenges.
• Customers and partners are not expected to be directly impacted by the delisting, according to the company.

Next Steps

• The company will transition its stock trading to the OTC Pink Market.
• The company will continue discussions to secure interim financing.
• The company will continue to operate its business and meet its SEC reporting obligations.

Key Dates

Keywords

delisting, NYSE, OTC Pink Market, market capitalization, liquidity, interim financing, physical therapy, stock, trading, financial risk